Cost‐effectiveness of antifungal prophylaxis, preemptive therapy, or empiric treatment following allogeneic hematopoietic stem cell transplant-Reference-Cited by-同舟云学术

Cost‐effectiveness of antifungal prophylaxis, preemptive therapy, or empiric treatment following allogeneic hematopoietic stem cell transplant

Published:2019-08-19 Issue:5 Volume:21 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Walker Brandon S.¹^ORCID,Schmidt Robert L.¹²,Tantravahi Srinivas³,Kim Kibum²,Hanson Kimberly E.¹²⁴

Affiliation:

1. ARUP Laboratories Salt Lake City UT USA

2. Department of Pathology University of Utah Health Sciences Center Salt Lake City UT USA

3. Department of Medicine, Division of Hematology University of Utah Health Sciences Center Salt Lake City UT USA

4. Department of Medicine, Infectious Diseases Division University of Utah Health Sciences Center Salt Lake City UT USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13148

Reference81 articles.

1. Epidemiology of Invasive Mold Infections in Allogeneic Stem Cell Transplant Recipients: Biological Risk Factors for Infection According to Time after Transplantation

2. Economic analysis of empiric versus diagnostic‐driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China;Mao N;Clinicoecon Outcomes Res,2016

3. Cost-Effectiveness Analysis Comparing Two Approaches for Empirical Antifungal Therapy in Hematological Patients with Persistent Febrile Neutropenia

4. Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China

5. Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on pharmacotherapy for fungal infections in allogeneic stem cell transplant recipients;Expert Opinion on Pharmacotherapy;2024-07-23

2. Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection;Open Forum Infectious Diseases;2024-07-23

3. Comparison of the safety and cost-effectiveness of nebulized liposomal amphotericin B and amphotericin B deoxycholate for antifungal prophylaxis after lung transplantation;Journal of Infection and Chemotherapy;2024-02

4. Optimization of Antimicrobial Stewardship Programs Using Therapeutic Drug Monitoring and Pharmacokinetics–Pharmacodynamics Protocols: A Cost-Benefit Review;Therapeutic Drug Monitoring;2023-01-02

5. Costs of matched-sibling, unrelated, and haploidentical hematopoietic cell transplantation and risk factors for greater financial burden — a Brazilian FACT-accredited single-center analysis;Annals of Hematology;2022-09-12